Hang Seng Index Rebalance Preview - September 2019
The Hang Seng Indexes Company Limited (HSIL) will announce the results of the 2019 Q2 review of the Hang Seng Family of Indexes on 16 August. The...
816 Views
HK Connect Ideas: Six Weeks of Inflows, BEW, Solars (2019-06-21)
In our weekly HK Connect Snippet series, we aim to help our investors understand the flow of southbound trades via the Hong Kong Connect, as...
346 Views
Last Week in GER Research: Wuxi Biologics Placement, Budweiser APAC IPO, Slack and CIMC Direct
Below is a recap of the key IPO and fundamental research produced by the Global Equity Research team. This week we update on the placement by Wuxi...
287 Views
WuXi Biologics Placement: Attractive in the Context of Market, Financials and Valuation
Wuxi Biologics (Cayman) Inc (2269 HK) is a global one-stop biologics services provider and often referred to as CRO (contract research...
583 Views
Wuxi Biologics Placement: Past Deal Did Well Despite Sell-Down Overhang
Biologics holdings is looking to raise upto US$495m by selling a 4.4% stake in Wuxi Biologics (Cayman) Inc (2269 HK). This will be fifth placement...
650 Views